(Rac)-Sograzepide is an antagonist of cholecystokinin B (CCK-B) receptor , and has the potential of reducing the secretion of gastric acid.
In Vitro
(Rac)-Sograzepide is an antagonist of CCK-B receptor, and has the potential of reducing the secretion of gastric acid. MCE has not independently confirmed the accuracy of these methods. They are for reference only.